ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MOL Moleculin Biotech Inc

0.00
0.00 (0.00%)
- - Closed
Realtime Data
Share Name Share Symbol Market Type
Moleculin Biotech Inc TG:MOL Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

MOL Sees 2015 Clean EBITDA at $2 Billion

24/02/2015 1:20am

Dow Jones News


Moleculin Biotech (TG:MOL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Moleculin Biotech Charts.

BUDAPEST--MOL Nyrt. (MOL.BU), one of central Europe's largest refineries and Hungary's biggest company by revenue, expects to see earnings before interest, taxes, depreciation and amortization at $2 billion, according to a video interview with the company's managers published Tuesday.

The firm plans to reach this in line with its new, three-year downstream program that includes cost efficiency measures in the production, commercial and retail areas; as well as the financial return of the last two or three years' strategic investments, Jozsef Simola, MOL's chief operating officer said.

The planned 2015 EBITDA compares to $592 million in 2014, and is calculated with a crude oil price forecast of $60 per barrel.

The firm published its 2014 earnings earlier Tuesday.

Over the next three years, MOL plans downstream EBITDA between $1.3 billion and $1.4 billion, while free cash flow is forecast around $900 million.

Ferenc Horvath, MOL's executive vice president for the downstream business, said this year would be as challenging as 2014 was or even more, but was confident that MOL was ready to tackle the challenges.

Write to Veronika Gulyas at veronika.gulyas@wsj.com; Twitter: @VeronikaGulyas1

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Moleculin Biotech Chart

1 Year Moleculin Biotech Chart

1 Month Moleculin Biotech Chart

1 Month Moleculin Biotech Chart